div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F Hoffmann-La Roche Ltd Editorial support funded by the sponsor src=https:reader035fdocumentsinreader035viewer20220707195edef41cad6a402d666a509chtml5thumbnails1jpg width=142 height=106 layout=responsive amp-img divpSABCS 2018pdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F Hoffmann-La Roche Ltd Editorial support funded by the sponsor src=https:reader035fdocumentsinreader035viewer20220707195edef41cad6a402d666a509chtml5thumbnails2jpg width=142 height=106 layout=responsive amp-img divpSABCS 2018pdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F Hoffmann-La Roche Ltd Editorial support funded by the sponsor src=https:reader035fdocumentsinreader035viewer20220707195edef41cad6a402d666a509chtml5thumbnails3jpg width=142 height=106 layout=responsive amp-img divpSABCS 2018pdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F Hoffmann-La Roche Ltd Editorial support funded by the sponsor src=https:reader035fdocumentsinreader035viewer20220707195edef41cad6a402d666a509chtml5thumbnails4jpg width=142 height=106 layout=responsive amp-img divpSABCS 2018pdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: SABCS 2018 - oncoletter€¦ · committee member for the IMpassion130 and KATE2 trials This study is sponsored by F Hoffmann-La...